Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
Effective January 21, 2021, the Board of Directors of STAAR Surgical Company
appointed Dr. Elizabeth Yeu, 43, and Dr. K. Peony Yu, 58, to serve as
directors. The Board of Directors increased the size of the Board from six to
eight members. Dr. Yeu and Dr. Yu will each receive the standard director
compensation for a director, pro-rated for the remaining portion of the
2020-2021 term.
Dr. Yeu, has been a Partner at Virginia Eye Consultants since 2014. She also
currently serves as Secretary and a member of the Executive Committee of the
American Society of Cataract and Refractive Surgery (ASCRS). Dr. Yeu is a
nationally recognized ophthalmologist and educator. She has authored hundreds of
articles and is a frequent lecturer in the areas of refractive cataract surgery,
anterior segment reconstruction, ocular surface disease management and surgical
management of astigmatism. Dr. Yeu earned her medical degree through an
accelerated and combined undergraduate/medical school program at the University
of Florida College of Medicine. Dr. Yeu completed her residency at Rush
University Medical Center and fellowship in cornea, anterior segment and
refractive surgery at Baylor College of Medicine.
Dr. Yu brings more than 25 years of biomedical leadership, patient care, and
medical device development experience with expertise in clinical and regulatory
process, and with multiple prior successful product approvals for patients in
multiple global regions, including US, Europe, China, Japan, and others. Dr, Yu
served as Chief Medical Officer, FibroGen Inc., a publicly-traded
biopharmaceutical company until December 2020. She initially joined FibroGen in
2008 as Vice President, Clinical Development. Prior to joining FibroGen, Dr. Yu
served as Vice President of Clinical Research at Anesiva Inc, following roles of
increasing responsibilities in Clinical Development at ALZA Corporation, Johnson
& Johnson; Pain Therapeutics Inc. (now Cassava Sciences Inc); and Elan
Corporation plc (now Perrigo Company plc). Earlier in her career, Dr. Yu was
Head of the Department of Physical Medicine & Rehabilitation at the Palo Alto
Medical Foundation. Dr. Yu received a B.S. in Chemical Engineering from
University of California, Davis, and an M.D. from the UC Davis School of
Medicine. She completed her residency training at Stanford University School of
Medicine.
The Company also reported today that Mr. John Moore, 77, who has served as a
member of the Board of Directors since 2008, has chosen to retire from the Board
of Directors when his current term expires, effective at STAAR's 2021 Annual
Shareholders Meeting. After these announcements, there are currently eight
members of the Board and it will decrease to seven members after the 2021 Annual
Shareholders Meeting.
The Nominating and Governance Committee has not yet assigned committee
memberships for Dr. Yeu and Dr. Yu. The appointments of Dr. Yeu and Dr. Yu to
the Board were not the result of any arrangement or understanding between Dr.
Yeu or Dr. Yu and any other person or entity. There are no related person
transactions between Dr. Yeu or Dr. Yu nor any member of either of their
immediate families, and the Company or any of its subsidiaries.
The information furnished herewith pursuant to Item 5.02 of this Current Report,
including Exhibit 99.1, shall not be deemed to be "filed" for the purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), or otherwise subject to the liabilities of that section. The information
in Item 5.02 of this Current Report shall not be incorporated by reference into
any filing under the Securities Act of 1933, as amended, or the Exchange Act,
whether made before or after the date of this Current Report, regardless of any
general incorporation language in the filing.
Item 9.01 Financial Statements and Exhibits
Exhibit No. Description
99.1 Press release of the Company dated January 26,
2021 .
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document).
© Edgar Online, source Glimpses